Small molecule inhibitors have become a valuable tool in the development of targeted therapies against cancer, as they are highly selective and effective against specific protein kinases [14], and they present a more favorable side effect profile than conventional cytotoxic chemotherapy [15]. Here, WEE1 is linked to cancer.